West Michael D

BioTime Inc.

Co-Chief Executive Officer, Director

Avg. Two Year Performance

(22%) Avg. Purchase Return (10%) Compound

(3%) Avg. Sale Return (1%) Compound

Holdings: 893.91K shares

Last Three Months: 24-Aug-24 -- 23-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

24-Nov-22 -- 23-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions